Evidence map›Paper›PMID 31794431›Full record

ArticleThe Journal of clinical investigation2020

Lysine acetyltransferase 8 is involved in cerebral development and syndromic intellectual disability.

Lin Li, Mohammad Ghorbani, Monika Weisz-Hubshman, Justine Rousseau, Isabelle Thiffault, Rhonda E Schnur, Catherine Breen, Renske Oegema, Marjan Mm Weiss, Quinten Waisfisz and 24 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 68 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Fto-mediated mJournal of biomedical science · 2025
    Article
  11. Review
  12. Basic Epigenetic Mechanisms.Sub-cellular biochemistry · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. mNature communications · 2024
    Article
  17. Article
  18. Article
  19. Review
  20. Key variants via the Alzheimer's Disease Sequencing Project whole genome sequence data.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 14 institutions in 6 countries.

Lin LiRosalind and Morris Goodman Cancer Research Centre and Department of Medicine, McGill University, Montreal, Quebec, Canada.
Mohammad GhorbaniRosalind and Morris Goodman Cancer Research Centre and Department of Medicine, McGill University, Montreal, Quebec, Canada.
Monika Weisz-HubshmanPediatric Genetics Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Justine RousseauPaediatric Department, CHU Sainte-Justine Hospital, University of Montreal, Quebec, Canada.
Isabelle ThiffaultCenter for Pediatric Genomic Medicine & Division of Clinical Genetics, Children's Mercy Hospital, Kansas City, Missouri, USA.
Rhonda E SchnurDivision of Genetics, Cooper University Health Care, Camden, New Jersey, USA.
Catherine BreenManchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Saint Mary's Hospital, Manchester, United Kingdom.
Renske OegemaDepartment of Genetics, University Medical Center Utrecht, Utrecht, Netherlands.
Marjan Mm WeissDepartment of Clinical Genetics, Amsterdam University Medical Center, Amsterdam, Netherlands.
Quinten WaisfiszDepartment of Clinical Genetics, Amsterdam University Medical Center, Amsterdam, Netherlands.
Sara WelnerDivision of Pediatric Medical Genetics, The State University of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
Helen KingstonManchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Saint Mary's Hospital, Manchester, United Kingdom.
Jordan A HillsUniversity of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Elles Mj BoonDepartment of Clinical Genetics, Amsterdam University Medical Center, Amsterdam, Netherlands.
Lina Basel-SalmonPediatric Genetics Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Osnat KonenSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Hadassa Goldberg-SternSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Lily BazakRaphael Recanati Genetic Institute, Rabin Medical Center, Petach Tikva, Israel.
Shay TzurLaboratory of Molecular Medicine, Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa, Israel.
Jianliang JinRosalind and Morris Goodman Cancer Research Centre and Department of Medicine, McGill University, Montreal, Quebec, Canada.
Xiuli BiRosalind and Morris Goodman Cancer Research Centre and Department of Medicine, McGill University, Montreal, Quebec, Canada.
Michael BruccoleriRosalind and Morris Goodman Cancer Research Centre and Department of Medicine, McGill University, Montreal, Quebec, Canada.
Kirsty McWalterGeneDx, Gaithersburg, Maryland, USA.
Megan T ChoGeneDx, Gaithersburg, Maryland, USA.
Maria ScaranoDivision of Genetics, Cooper University Health Care, Camden, New Jersey, USA.
G Bradley SchaeferUniversity of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Susan S BrooksDivision of Pediatric Medical Genetics, The State University of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
Susan Starling HughesCenter for Pediatric Genomic Medicine & Division of Clinical Genetics, Children's Mercy Hospital, Kansas City, Missouri, USA.
K L I van GassenDepartment of Genetics, University Medical Center Utrecht, Utrecht, Netherlands.
Johanna M van HagenDepartment of Clinical Genetics, Amsterdam University Medical Center, Amsterdam, Netherlands.
Tej K PanditaDepartment of Radiation Oncology, Houston Methodist Research Institute, Houston, Texas, USA.
Pankaj B AgrawalDivisions of Newborn Medicine and Genetics and Genomics, The Manton Center for Orphan Disease Research, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Philippe M CampeauPaediatric Department, CHU Sainte-Justine Hospital, University of Montreal, Quebec, Canada.
Xiang-Jiao YangRosalind and Morris Goodman Cancer Research Centre and Department of Medicine, McGill University, Montreal, Quebec, Canada.
McGill University Health Centre · CAAmsterdam University Medical Centers · NLRafael Advanced Defense Systems (Israel) · ILCentre Hospitalier Universitaire Sainte-Justine · CAChildren's Mercy Hospital · USCooper University Health Care · USRutgers, The State University of New Jersey · USSt Mary's Hospital · GBTel Aviv University · ILUniversity Medical Center Utrecht · NLUniversity of Arkansas for Medical Sciences · USBoston Children's Hospital · USHouston Methodist · USRappaport Family Institute for Research in the Medical Sciences · IL

Funding

CHROMATIN MODIFYING FACTORS CONTROL RADIATION RESPONSE AND GENOMIC STABILITYR01CA129537 · NCI · WASHINGTON UNIVERSITY · PI PANDITA, TEJ K · 2008 to 2018
$3.3M
Role of Heterochromatin protein 1 Beta in Genome Maintenance and OncogenesisR01GM109768 · NIGMS · METHODIST HOSPITAL RESEARCH INSTITUTE · PI PANDITA, TEJ K · 2014 to 2017
$1.2M
NCI NIH HHS R01 CA129537NIGMS NIH HHS R01 GM109768Wellcome Trust
6 · The paper itself

Abstract

Epigenetic integrity is critical for many eukaryotic cellular processes. An important question is how different epigenetic regulators control development and influence disease. Lysine acetyltransferase 8 (KAT8) is critical for acetylation of histone H4 at lysine 16 (H4K16), an evolutionarily conserved epigenetic mark. It is unclear what roles KAT8 plays in cerebral development and human disease. Here, we report that cerebrum-specific knockout mice displayed cerebral hypoplasia in the neocortex and hippocampus, along with improper neural stem and progenitor cell (NSPC) development. Mutant cerebrocortical neuroepithelia exhibited faulty proliferation, aberrant neurogenesis, massive apoptosis, and scant H4K16 propionylation. Mutant NSPCs formed poor neurospheres, and pharmacological KAT8 inhibition abolished neurosphere formation. Moreover, we describe KAT8 variants in 9 patients with intellectual disability, seizures, autism, dysmorphisms, and other anomalies. The variants altered chromobarrel and catalytic domains of KAT8, thereby impairing nucleosomal H4K16 acetylation. Valproate was effective for treating epilepsy in at least 2 of the individuals. This study uncovers a critical role of KAT8 in cerebral and NSPC development, identifies 9 individuals with KAT8 variants, and links deficient H4K16 acylation directly to intellectual disability, epilepsy, and other developmental anomalies.

Indexed as

AcetylationAnimalsHEK293 CellsHippocampusHistone AcetyltransferasesHumansIntellectual DisabilityMiceMice, KnockoutNeocortexNeural Stem CellsNucleosomesHistone AcetyltransferasesKAT8 protein, humanKat8 protein, mouseNucleosomesEpigeneticsNeuroscience

Identifiers

PMID31794431
PMCPMC7269600
OpenAlexW2993062663

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.